Under the Medicare Part D outpatient prescription drug benefit program, Part D plans are required to cover a minimum of two drugs in each therapeutic category and class, but from the outset, Medicare has been prohibited by law from covering medications when used specifically for weight loss
For many people experiencing significant weight loss on tirzepatide compound protocols , the thigh becomes the primary injection site as abdominal fat decreases
Use within 28 days after initial use
Short-acting GLP-1 agonists like exenatide (taken twice daily) may produce more immediate effects on post-meal glucose levels, whilst longer-acting weekly formulations such as semaglutide or dulaglutide provide more sustained action but may take longer to reach steady-state concentrations in the body
Adherence Barriers Even after overcoming access barriers and obtaining the medication, many patients struggle with adherence
When it comes to how theyre taken, there are some similarities: Advertisement Some people use Ozempic and experience weight loss as a side effect